Evidence Revealing Deregulation of The KLF11-Mao A Pathway in Association with Chronic Stress and Depressive Disorders

• Published in: Neuropsychopharmacology (New York, N.Y.) Vol. 40; no. 6; pp. 1373 - 1382
• Main Authors: Harris, Sharonda, Johnson, Shakevia, Duncan, Jeremy W, Udemgba, Chinelo, Meyer, Jeffrey H, Albert, Paul R, Lomberk, Gwen, Urrutia, Raul, Ou, Xiao-Ming, Stockmeier, Craig A, Wang, Jun Ming
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 01.05.2015
• Subjects: Animals; Apoptosis Regulatory Proteins; Cell Cycle Proteins - metabolism; Chronic Disease; Depressive Disorder, Major - metabolism; Disease Models, Animal; DNA-Binding Proteins - genetics; DNA-Binding Proteins - metabolism; Dominance-Subordination; Enzymes; Female; Frontal Lobe - metabolism; Growth factors; Human subjects; Humans; Laboratories; Male; Mental depression; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Monoamine Oxidase - metabolism; Motor Activity - physiology; Neurosciences; Original; Pathogenesis; Proteins; Psychiatry; Repressor Proteins - metabolism; Severity of Illness Index; Stress; Stress, Psychological - metabolism; Transcription Factors - genetics; Transcription Factors - metabolism; Up-Regulation; Canada; United States > US
• ISSN: 0893-133X; 1740-634X; 1740-634X
• DOI: 10.1038/npp.2014.321

The biochemical pathways underlying major depressive disorder (MDD) and chronic stress are not well understood. However, it has been reported that monoamine oxidase A (MAO A, a major neurotransmitter-degrading enzyme) is significantly increased in the brains of human subjects affected with MDD and rats exposed to chronic social defeat (CSD) stress, which is used to model depression. In the current study, we compared the protein levels of a MAO A-transcriptional activator, Kruppel-like factor 11 (KLF11 , also recognized as transforming growth factor-beta-inducible early gene 2) between the brains of 18 human subjects with MDD and 18 control subjects. We found that, indeed, the expression of KLF11 is increased by 36% (p<0.02) in the postmortem prefrontal cortex of human subjects with MDD compared with controls. We also observed a positive correlation between KLF11 levels and those of its target gene, MAO A, both in association with MDD. KLF11 protein expression was also increased by 44% (p<0.02) in the frontal cortex of KLF11 wild-type mice (Klf11(+/+)) vs Klf11(-/-) when both exposed to CSD stress. In contrast, locomotor activities, central box duration and sucrose preference were significantly reduced in the stressed Klf11(+/+) mice, suggesting that Klf11(+/+) mice are more severely affected by the stress model compared with Klf11(-/-) mice. These results serve to assign an important role of KLF11 in upregulating MAO A in MDD and chronic social stress, suggesting that inhibition of the pathways regulated by this transcription factor may aid in the therapeutics of neuropsychiatric illnesses. Thus, the new knowledge derived from the current study extends our understanding of transcriptional mechanisms that are operational in the pathophysiology of common human diseases and thus bears significant biomedical relevance.